Lipid rafts as viral entry routes and immune platforms: A double-edged sword in SARS-CoV-2 infection?

Roncato, Rossana; Angelini, Jacopo; Pani, Arianna; Talotta, Rossella

Roncato, Rossana; Angelini, Jacopo; Pani, Arianna; Talotta, Rossella.

Afiliación

Roncato R; Experimental and Clinical Pharmacology Unit, Centro di Riferimento Oncologico di Aviano (CRO), Istituto di Ricovero e Cura a carattere Scientifico (IRCCS), via Gallini, 33081 Aviano (PN), Italy.
Angelini J; Clinical Pharmacology Institute, Azienda Sanitaria Universitaria Friuli Centrale (ASU FC), via Pozzuolo, 33100 Udine, Italy.
Pani A; Toxicology Department of Oncology and Hemato-Oncology, University of Milan, via Vanvitelli, 20133 Milan, Italy.
Talotta R; Department of Clinical and Experimental Medicine, Rheumatology Unit, AOU "Gaetano Martino", University of Messina, 98100 Messina, Italy.

Biochim Biophys Acta Mol Cell Biol Lipids ; 1867(6): 159140, 2022 06.

Article en En | MEDLINE | ID: mdl-35248801

Asunto(s)

Tratamiento Farmacológico de COVID-19; Internalización del Virus; Humanos; Lípidos; Microdominios de Membrana; SARS-CoV-2

Palabras clave

Anticoagulant drugs; Antiviral drugs; COVID-19; Immunosuppressive drugs; Lipid rafts; Lipid-lowering drugs; Monoclonal antibodies; SARS-CoV-2

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Internalización del Virus / Tratamiento Farmacológico de COVID-19 Límite: Humans Idioma: En Revista: Biochim Biophys Acta Mol Cell Biol Lipids Año: 2022 Tipo del documento: Article País de afiliación: Italia

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google